Kukje Pharma Report issue

For profit Phase 1 Phase 3
Founded: Seongnam Korea, Republic of (1959)
Status: No NME R&D (1959)

Organization Overview

First Clinical Trial
2016
NCT02967614
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Kukje Pharma

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Eye Diseases (Phase 1)

Gastritis (Phase 1)

Ocular Hypertension (Phase 1)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 4
  • # of Trial APIs: 7